Interventional Technologies
VASCADE MVP XL_Logo(AA)-RED-RGB

NOW INDICATED FOR venous vascular closure in 10-14F ID/17F max OD sheaths.

The Only Extravascular Venous Closure System Clinically Proven in EP Procedures using 17F OD Procedural Sheaths.

26HMO048_mvpxl_web_graphics

The AMBULATE EXPAND Trial

Summary

Prospective, single arm pivotal trial at 8 U.S. centers to evaluate femoral venotomy after catheter-based procedures using 10-14F ID/17F max OD sheaths. Demonstrated safety and efficacy of the VASCADE MVP® XL venous vascular closure system in 77 patients as follows:1

  • 0% major complications*

  • 0% minor complications†

  • Median 2.4 hours time to ambulation (TTA)‡

  • Median 2.3 minutes time to hemostasis (TTH)

  • Median 2.7 hours time to discharge eligibility (TTDE)

26HMO048_mvpxl_web_graphics-02
26HMO048_mvpxl_web_graphics-03
26HMO048_mvpxl_web_graphics-04

Request Information

Fill out the form below and we will be happy to send you more information.
* Major venous access site closure-related complications through 30-day follow up
† Minor venous access site closure-related complications through 30-day follow up
‡ In Per Protocol population (N=66)
1. VASCADE MVP XL IFU 4911
COL-COPY-002744-US(AA)